Wednesday, December 8, 2021  | 3 Jamadilawal, 1443
Samaa TV
Facebook Twitter Youtube
HOME > Health

Coronavirus vaccine trials start this week in Pakistan: taskforce chairperson

Vaccine to be available for whole population by mid-2021

SAMAA | - Posted: Sep 21, 2020 | Last Updated: 1 year ago
Posted: Sep 21, 2020 | Last Updated: 1 year ago

Clinical trials for a vaccine for the novel coronavirus will start this week in Pakistan, says Attaur Rehman, the chairperson of the Prime Minister’s Task Force on Science and Technology.

The COVID-19 vaccine will be produced by a “well acclaimed international company”, added Dr Rahman, reported Radio Pakistan on September 20.

The chairman said the International Center for Chemical and Biological Sciences based at the University of Karachi has been approved for the vaccine trials. Once the trials are completed, the vaccine will be available for everyone between April and June next year (2021).

In August, the National Ministry of Health Services had said the vaccine will be made available to all high-risk people on a priority basis. Healthcare professionals, government officials, elderly people and those with underlying illness are included in the high-risk population.

The National Institute of Health in Islamabad has approved phase III clinical trials in the country for a coronavirus vaccine developed by China. The approved vaccine was one of the two experimental vaccines China’s Beijing-based Sinovac Biotech had developed for COVID-19.

FaceBook WhatsApp

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp


Lahore-Sialkot motorway rape: a timeline
MG Motors increases prices of HS, ZS models
Railways suspends two drivers for stopping train to buy Dahi
PM: ‘From now on’ govt won’t allow misuse of religion
Karachi to pay Rs3.75 per unit more for September electricity
Lahore motorway rape convict appeals death sentence
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp